# Isa (Jatropha curcas)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/isa-jatropha-curcas
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Jatropha curcas L., Isa, Physic nut, Purging nut, Barbados nut, Piñón blanco, Tempate, Coquillo

## Overview

Jatropha curcas contains phorbol esters, diterpenoids (jatrophane alkaloids), phenolics, saponins, and the toxalbumin curcin, which collectively exert cytotoxic, [antimicrobial](/ingredients/condition/immune-support), and antioxidant effects through membrane disruption, free-radical scavenging, and apoptosis induction in tumor cell lines. In vitro, a methanolic seed kernel extract demonstrated cytotoxicity against MCF-7 breast cancer cells at a CC₅₀ of 27.5 μg/mL (compared to tamoxifen at 17.3 μg/mL, P=0.0001), while leaf ethyl acetate extracts achieved 82.6% [antioxidant activity](/ingredients/condition/antioxidant) versus ascorbic acid at 86.2%.

## Health Benefits

- **[Antimicrobial](/ingredients/condition/immune-support) Activity**: Stem ethanol extracts (20%) produced inhibition zones of up to 40 mm against Klebsiella pneumoniae, and leaf extracts inhibited Staphylococcus sp. (17 mm) and E. coli (52 mm), attributed to saponins and alkaloids disrupting bacterial membrane integrity.
- **Antioxidant Potential**: Leaf extracts scavenge [free radical](/ingredients/condition/antioxidant)s at 82.6% efficiency (comparable to ascorbic acid at 86.2%), driven by phenolic and flavonoid hydrogen-atom donation that reduces Fe³⁺ to Fe²⁺ in ferric-reducing assays.
- **Anticancer Cytotoxicity (Preclinical)**: Methanolic extracts show CC₅₀ values of 27.5 μg/mL against MCF-7 breast cancer cells and 63.9 μg/mL against liver cell lines in vitro, with jatrophane diterpenoids implicated in apoptosis pathway activation.
- **Traditional Wound and Skin Healing**: Latex and leaf poultices have been applied topically across African and South American ethnomedicine to promote wound closure and reduce local infection, consistent with demonstrated antimicrobial and [anti-inflammatory](/ingredients/condition/inflammation) phytochemical profiles.
- **Purgative Action (Bolivian Traditional Use)**: Curcin, a ribosome-inactivating protein in seeds, and irritant phorbol esters (3.0 mg/g DM) produce potent cathartic effects when small seed doses are used in supervised Bolivian folk medicine for constipation and intestinal parasites.
- **Anti-inflammatory Properties**: Steroids, β-sitosterol (13.8% w/w in methanolic extract), and phenolic compounds in stems and roots have demonstrated anti-inflammatory potential in ethnopharmacological contexts by modulating prostaglandin-related pathways.
- **Nutritional Protein Source (Detoxified Meal)**: Defatted seed kernels contain 61.8% crude protein with low neutral detergent fiber (9.7%) and acid detergent fiber (4.8%), representing a high-protein meal candidate for livestock or human use contingent on complete phorbol ester removal.

## Mechanism of Action

Phenolic compounds and flavonoids (total phenolics 3.9 mg tannic acid equivalents/g DM; flavonoids 0.4 mg rutin equivalents/g DM) donate hydrogen atoms or electrons to neutralize [reactive oxygen species](/ingredients/condition/antioxidant), reducing Fe³⁺ to Fe²⁺ and interrupting lipid peroxidation cascades. Saponins (19.0 mg diosgenin equivalents/g DM) and alkaloids (0.6280% in leaves) intercalate into bacterial and fungal phospholipid bilayers, increasing membrane permeability, ion leakage, and cell lysis, explaining broad-spectrum [antimicrobial](/ingredients/condition/immune-support) effects observed across multiple extraction solvents. Jatrophane diterpenoids and curcin (a type II ribosome-inactivating protein) inhibit protein synthesis in eukaryotic cells and may induce mitochondria-mediated apoptosis in cancer cell lines, as evidenced by MCF-7 cytotoxicity at CC₅₀ 27.5 μg/mL. Phorbol esters act as protein kinase C (PKC) activators, which at low controlled doses modulate immune signaling but at typical seed concentrations cause pro-[inflammatory](/ingredients/condition/inflammation) and co-carcinogenic responses, defining the narrow and dangerous therapeutic window of the crude plant material.

## Clinical Summary

No human clinical trials evaluating Jatropha curcas (Isa) for any therapeutic indication have been published in the peer-reviewed literature as of the most recent evidence review. All quantitative outcome data derive from in vitro cell-based assays and agar-diffusion [antimicrobial](/ingredients/condition/immune-support) tests, which cannot confirm efficacy, effective dose, or safety in living human subjects. The most clinically relevant in vitro finding is MCF-7 breast cancer cell cytotoxicity at CC₅₀ 27.5 μg/mL, which, while statistically significant compared to tamoxifen (P=0.0001), represents an early-stage signal requiring animal pharmacokinetic studies and Phase I dose-escalation trials before any clinical inference can be drawn. Confidence in therapeutic application is very low; the primary driver of this limitation is the documented toxicity of phorbol esters and curcin in seeds, which creates substantial safety barriers to human trial design.

## Nutritional Profile

Defatted seed kernels: crude protein 61.8 ± 0.11% DM (high biological value potential pending detoxification), neutral detergent fiber 9.7 ± 0.52% DM, acid detergent fiber 4.8 ± 0.21% DM. Leaves: moisture 89.70%, crude protein approximately 4.35% fresh weight, with low caloric density; phytochemical constituents include alkaloids (0.6280%), saponins (0.4210%), tannins, phenols, steroids, phlobatannins, and cardiac glycosides. Seed kernel methanolic extracts contain total phenolics (3.9 ± 0.23 mg tannic acid equivalents/g DM), flavonoids (0.4 ± 0.15 mg rutin equivalents/g DM), and saponins (19.0 ± 0.48 mg diosgenin equivalents/g DM). Phorbol esters in seeds reach 3.0 ± 0.16 mg/g DM — a critical anti-nutritional factor that severely limits bioavailability of otherwise high-quality seed protein and renders the raw kernel unsuitable for human or monogastric animal consumption without validated detoxification. β-Sitosterol, identified by GC-MS at 13.8% w/w in methanolic stem extract, contributes phytosterol content with potential cholesterol-modulating relevance if safely extracted.

## Dosage & Preparation

- **Traditional Bolivian Purgative Use**: 1–2 seeds (unprocessed) historically administered orally under supervised traditional healer guidance; this practice is associated with serious toxicity risk and is not endorsed by regulatory authorities.
- **Leaf Poultice (Topical)**: Fresh leaves crushed and applied directly to wounds or inflamed skin in African and South American ethnomedicine; no standardized preparation or dose established.
- **20% Ethanol Stem Extract (Laboratory Standard)**: Used in [antimicrobial](/ingredients/condition/immune-support) disk-diffusion research; concentration not translatable to a human supplemental dose.
- **Methanolic Seed Kernel Extract (Research Only)**: Prepared by Soxhlet or maceration at room temperature; CC₅₀ values derived at 27.5 μg/mL in cell assays — no human-equivalent dose can be calculated.
- **Hot Water (Decoction)**: Leaves decocted in traditional use for fever and infections; no controlled preparation protocol or dose-response data available.
- **Detoxified Kernel Meal (Experimental Nutritional Use)**: Detoxification via heat treatment or solvent washing to reduce phorbol esters below 0.1 mg/g DM is under investigation for animal feed; human food application remains unapproved.
- **NOTE**: No standard supplemental dose, bioavailability figure, or approved commercial formulation exists for human use; self-administration of any Jatropha curcas preparation is strongly discouraged given documented toxicity.

## Safety & Drug Interactions

The primary safety concern for Jatropha curcas is phorbol ester content (3.0 mg/g DM in seed kernels), which are potent protein kinase C activators known to cause severe gastrointestinal toxicity (nausea, vomiting, violent diarrhea, abdominal pain), systemic [inflammation](/ingredients/condition/inflammation), and are classified as tumor promoters and co-carcinogens at chronic sublethal exposures; ingestion of even 1–3 unprocessed seeds has caused serious poisoning in children and adults. Curcin, a type II ribosome-inactivating protein analogous to ricin in mechanism, inhibits eukaryotic protein synthesis and contributes to cytotoxicity at CC₅₀ 63.9 μg/mL in liver cells (in vitro), raising serious hepatotoxicity concerns with systemic exposure. No formal drug interaction studies exist; however, the high saponin content (19.0 mg diosgenin equivalents/g DM) may theoretically potentiate or interfere with cardiac glycosides, and phorbol ester-mediated PKC activation could interfere with PKC-modulating therapeutics (e.g., protein kinase inhibitors used in oncology). Jatropha curcas preparations are contraindicated in pregnancy (purgative and potentially abortifacient effects), lactation, pediatric populations, and individuals with gastrointestinal disorders, hepatic impairment, or cancer therapy regimens; no maximum safe dose for humans has been established.

## Scientific Research

The available evidence base for Jatropha curcas consists entirely of in vitro [antimicrobial](/ingredients/condition/immune-support) disk-diffusion assays, cell-line cytotoxicity studies, and phytochemical characterization studies; no peer-reviewed human clinical trials have been identified in the published literature. Antimicrobial studies report inhibition zones ranging from 8.0–13.7 mm (fruit flavonoid fractions) to 40 mm (20% ethanol stem extract vs. Klebsiella pneumoniae) and 52 mm (leaf extract vs. E. coli), though standardization of inoculum density and extract concentration varies substantially between studies, limiting comparability. The most quantitatively rigorous cytotoxicity datum is the MCF-7 CC₅₀ of 27.5 μg/mL from a methanolic seed kernel extract versus tamoxifen at 17.3 μg/mL (statistically significant at P=0.0001), but this in vitro result cannot be extrapolated to clinical efficacy or safety in humans without pharmacokinetic and toxicological bridging studies. Overall, the evidence base is preliminary and preclinical; the total absence of human trials, defined bioavailability data, or safety pharmacology studies in humans means that all reported activities should be interpreted as hypothesis-generating rather than clinically actionable.

## Historical & Cultural Context

Jatropha curcas has been used for centuries across indigenous communities in Mesoamerica, the Andean lowlands of Bolivia and Peru, and West Africa as a multipurpose medicinal plant, with Spanish colonial records from the 16th century documenting its purgative use in Central America under local names. In Bolivian ethnomedicine, the plant — referred to locally as 'Isa' — has been employed by traditional healers (curanderos) as a controlled cathartic for constipation, intestinal worm expulsion, and management of [inflammatory](/ingredients/condition/inflammation) skin conditions using latex applied topically. African traditional systems (particularly in Nigeria, Senegal, and Ghana) have independently developed parallel uses involving leaf and stem bark preparations for wound healing, toothache, and sexually transmitted infections, reflecting convergent ethnopharmacological knowledge across continents. The plant's dual identity as both a toxic substance and a controlled therapeutic agent exemplifies the concept of 'poison as medicine' found broadly in Andean and African healing traditions, where dosage and preparation method determine therapeutic versus toxic outcome.

## Synergistic Combinations

No formally studied synergistic combinations involving Jatropha curcas extracts and other supplements or drugs have been reported in the peer-reviewed literature due to the early preclinical stage of research and predominant toxicity concerns. Ethnobotanically, Bolivian and African healers have occasionally combined Jatropha preparations with binding agents such as clay or activated charcoal-based traditional preparations to modulate the purgative intensity and reduce toxicity, suggesting an empirical harm-reduction synergy that warrants pharmacological investigation. In the context of detoxified seed meal protein, combination with amino acid-complementary legume proteins (e.g., lysine-rich legumes) has been proposed theoretically to optimize nutritional value, but no human feeding studies confirm this potential.

## Frequently Asked Questions

### Is Jatropha curcas (Isa) safe to consume as a supplement or food?

Jatropha curcas seeds and raw preparations are not safe for human consumption in unprocessed form due to phorbol esters (3.0 mg/g DM) and the toxalbumin curcin, which cause severe gastrointestinal toxicity, systemic inflammation, and potential carcinogenicity. No regulatory authority has approved any Jatropha curcas product for human dietary supplementation, and ingestion of raw seeds has caused documented poisoning cases. Detoxification processes capable of reducing phorbol esters to safe levels are still under experimental development and have not been validated for human food applications.

### What is curcin and why is it dangerous in Jatropha curcas?

Curcin is a type II ribosome-inactivating protein (RIP) found in Jatropha curcas seeds, structurally analogous in mechanism to ricin from castor beans (Ricinus communis), that halts eukaryotic protein synthesis by enzymatically depurinating 28S ribosomal RNA. In vitro studies show liver cell cytotoxicity at a CC₅₀ of 63.9 μg/mL, indicating significant hepatotoxic potential. Because curcin is a large protein, oral bioavailability in humans may be limited by gastrointestinal proteolysis, but mucosal irritation from phorbol esters compounds overall toxicity risk when seeds are consumed.

### What traditional medicinal uses does Jatropha curcas have in Bolivia?

In Bolivian traditional medicine, Jatropha curcas — known locally as 'Isa' — has been used by curanderos (traditional healers) primarily as a controlled purgative for constipation and intestinal parasite expulsion, exploiting the powerful cathartic action of seed phorbol esters and curcin at carefully titrated doses. Latex from the plant is applied topically to wounds, skin infections, and inflammatory lesions, a practice consistent with the plant's documented antimicrobial activity showing inhibition zones of 17–52 mm against Staphylococcus and E. coli in laboratory models. These uses reflect broader South American and African ethnopharmacological traditions where the plant's toxicity is managed through empirical dose control and preparation methods passed down through generations.

### Does Jatropha curcas have any proven anticancer effects in humans?

Jatropha curcas has demonstrated in vitro cytotoxicity against MCF-7 human breast cancer cells with a CC₅₀ of 27.5 μg/mL for methanolic seed kernel extracts, statistically significant compared to tamoxifen at 17.3 μg/mL (P=0.0001), with jatrophane diterpenoids and curcin proposed as active agents. However, no animal tumor model studies or human clinical trials have been conducted, meaning these results are entirely preclinical and cannot be interpreted as proof of anticancer efficacy in humans. The severe toxicity profile of the plant makes clinical translation highly challenging without significant pharmaceutical processing and targeted drug delivery development.

### What are the antimicrobial properties of Jatropha curcas and which parts of the plant are most active?

Multiple parts of Jatropha curcas exhibit antimicrobial activity in laboratory disk-diffusion assays: stem extracts (20% ethanol) produced the largest inhibition zone of 40 mm against Klebsiella pneumoniae, leaf extracts inhibited E. coli at 52 mm and Staphylococcus sp. at 17 mm, and fruit flavonoid fractions showed inhibition zones of 8.0–13.7 mm against various bacteria. The active compounds responsible include alkaloids, saponins, and flavonoids, which disrupt bacterial cell membranes by integrating into lipid bilayers and causing ion leakage and cell lysis. While these in vitro results are promising, no clinical studies have validated topical or systemic antimicrobial efficacy in human infections, and standardization of extract concentration across studies remains inconsistent.

### What is the difference between Jatropha curcas leaf extract and stem extract for antimicrobial benefits?

Jatropha curcas leaf extracts and stem extracts demonstrate different antimicrobial potencies against specific pathogens. Leaf extracts show stronger inhibition against E. coli (52 mm zones) and Staphylococcus sp. (17 mm), while stem ethanol extracts are particularly effective against Klebsiella pneumoniae (up to 40 mm inhibition zones). Both contain antimicrobial compounds like saponins and alkaloids, but their concentration and composition vary between plant parts, making extract source an important consideration for intended use.

### How does Jatropha curcas compare to common antioxidant supplements in terms of free radical scavenging?

Jatropha curcas leaf extracts demonstrate free radical scavenging efficiency of 82.6%, which is comparable to ascorbic acid (vitamin C), a well-established antioxidant standard. This equivalent antioxidant capacity suggests Jatropha curcas may offer similar protection against oxidative stress in vitro. However, human bioavailability studies are needed to determine whether this laboratory-measured antioxidant activity translates to similar benefits when consumed as a supplement.

### Who should avoid Jatropha curcas supplements due to safety concerns?

Jatropha curcas contains curcin, a toxic protein that can cause severe gastrointestinal effects, making it unsuitable for most populations without proper processing or clinical guidance. Pregnant women, nursing mothers, and children should avoid this ingredient due to insufficient safety data and the presence of potentially harmful compounds. Individuals with existing gastrointestinal disorders or those taking medications affecting digestion should consult a healthcare provider before considering any Jatropha curcas supplement.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*